Cholesterol lowering with inclisiran: a new chapter in the PCSK9 story book

Eur Heart J. 2023 Jan 7;44(2):139-141. doi: 10.1093/eurheartj/ehac656.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Cholesterol
  • Humans
  • Proprotein Convertase 9*
  • RNA, Small Interfering

Substances

  • ALN-PCS
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Cholesterol
  • RNA, Small Interfering